CAM interests urge support for ANH legal challenge (1)
10 October 2007
Following is an extract from the lastest (September 2003) issue of CAM magazine. The bid, by ANH, to overturn the EU supplement directive continues to be widely supported.
10 October 2007
Following is an extract from the lastest (September 2003) issue of CAM magazine. The bid, by ANH, to overturn the EU supplement directive continues to be widely supported.
10 October 2007
The following statement was released today by US attorney Ralph Fucetola, the 'vitamin lawyer'.
10 October 2007
A Nobel-prize winner has said people should be told to look after their health instead of expecting science to "come to their rescue with a pill".
10 October 2007
New watchdog to regulate the growing £1.6 billion industry.
10 October 2007
Irish Examiner reports on the proposed legal challenge of the EU Food Supplements Directive.
10 October 2007
Glucosamine, used by millions of consumers across Europe to ease the symptoms of arthritis, has been classified as a drug in two European countries.
10 October 2007
Study says daily multivitamin use by older adults could save $1.6 billion in Medicare costs over five years.
10 October 2007
Read on to see Sam Burcher's article from The Institute of Science in Society (UK), released today.
10 October 2007
Project: FANS highlight new study that reinforces importance of nutritional supplements.
10 October 2007
In the wake of the Pan recall, Australia is to see further restrictions on natural healthcare.
10 October 2007
Waxman/Dingell/Davis introduce New Supplement Bill
10 October 2007
Oct 22, 2003 represents a very notable day for health freedom. This is the day that Canada spoke out...
10 October 2007
The latest issue of CAM illustrates how medical researchers have opted for talk, not action, over concerns that drug company funding is influencing the results of clinical trials.
10 October 2007
Yet more research to support the efficacy of supplements in preventative health care.
10 October 2007
Paul Taylor; Independant Consumer Health Advocate provides an important and detailed report from the Nov 03 Codex meeting in Bonn.
10 October 2007
Is this a gaffe - or an attempt by a senior executive of a major pharmaceutical company to steer the industry in a new direction? Is this the dawn and justification for 'tailored drugs'?
This site uses cookies and other tracking technologies to assist with navigation, analyse your use of our products and services, and provide content from third parties.